Merck said on Tuesday it has opened a $1-billion facility at its North Carolina site, the latest drugmaker to boost its U.S.

Caroline Dubois successfully defended her WBC lightweight title against WBC No.1 contender Bo Mi Re Shin on a historic all-women’s card at the Royal Albert Hall on Friday evening. ‘Sweet ...

Princess Caroline of Hannover (often referred to as Princess Caroline of Monaco) was born in January 1957 - the eldest child of Rainier III, Prince of Monaco and Hollywood actress-turned-princess ...

At the Obesity Week meeting in November 2024, Harvard Obesity Expert Caroline M. Apovian ... s drug label and it needs to be…All Merck has to do is put it on their label,” Apovian said.

More than a decade after Merck’s Keytruda and BMS’ Yervoy ushered in the immuno ... IO treatment response rates have plateaued at around 30%, Caroline Loew, CEO of Mural Oncology, wrote in a November ...

The economic ripple effect is undeniable. USAID’s partnerships with New Jersey-based companies like Johnson & Johnson and Merck extend the state’s influence in global health initiatives while ...

Merck, also known as MSD outside the U.S. and Canada, plans to significantly expand its workforce in India, aiming for around 2,700 employees by the year's end. The company focuses on therapy areas ...

Reply to: Treatment Intensification Based on Residual Disease in Elderly Patients With AML ...

Carolyn Wiger is a “Survivor” icon — but even she doesn’t know if she’ll appear on Season 50. The 38-year-old reality star revealed that she’s too preoccupied with her experience on ...

On February 4, Merck released financial results for Q4 2024, which, as in previous quarters, once again beat analysts' expectations. This was driven by a strong performance by its oncology ...

Mer­ck said its “once-in-a-life­time” drug Keytru­da could be sub­ject to price re­duc­tions un­der the In­fla­tion Re­duc­tion Act, which would lead to a … ...

Merck is bracing for the years of sales growth from oncology superstar Keytruda to take a sharp turn in 2028—and for more reasons than one. Along with a key U.S. patent expiring at the end of ...